Pullbacks and top ratings in a pair of widely-traded ETFs helped guide active investors toward short-term profits this week.
Find out how a strategy of scaling-in to exchange-traded funds is a quantified way to take advantage of pullbacks, big and small.
A three-day sell-off in the transporation sector led to a short-term trading opportunity for active ETF investors.
When it comes to trading ETFs, wading into a position one toe at a time can be better than jumping in all at once with both feet.
From the plunge in Gilead Sciences to the vertigo-inducing rally in Vivus, the moves in biotech have been the most under-reported story on the Street this week.
Aggressive scale-in strategies for trading ETFs may be just what conservative traders are looking for.
Extreme conditions and bottom-of-heap ratings are an important component in identifying the best ETF markets to sell short.
Want to buy low and sell high? Let PowerRatings be your guide to buying weakness and selling strength when it comes to trading ETFs.
The S&P Biotech SPDRS ETF is one solution to trading the single-stock volatility of individual biotech companies.
Once again, a major ratings upgrade signals a short-term opportunity to fade the financials with ETFs.